Driving research and awareness by working together are ways in which the word cure might one day be heard in the ovarian cancer community. Members of the tight knit “teal army” gathered last night for the inaugural Ovarian Cancer Heroes … Read more
Despite showing an interest in clinical trials and biobanking, underserved populations appear to be unclear on how to learn about them, while community physicians reported lacking appropriate information to give them, according to data to be presented at the American … Read more
The U.S. government said on Friday it will pay for certain genetic tests for Medicare-eligible patients with advanced cancer, in a bid to help match patients with the drugs most likely to provide benefit.
The Centers for Medicare & Medicaid … Read more
As genetic testing becomes more accessible with advanced technology and decreased costs, population-based testing for breast and ovarian cancer may be more cost effective in the long run, according to study results published in Journal of the National Cancer Institute… Read more
Evidence is growing that all women age 30 and older should be tested for the inherited gene mutations that can cause breast and ovarian cancer, according to British researchers.
“We could prevent thousands more ovarian and breast cancers through a … Read more
I had a family member who was diagnosed with late stage ovarian cancer 20 years ago and died of the disease at the age of 47. Even though her symptoms appeared a year before her diagnosis with abdominal bloating, indigestion, … Read more
Whether you’ve already been diagnosed, or you want to know your risk, health experts can test your DNA to determine your chances of developing cancer.
“The testing itself determines whether or not they have inherited this broken gene that could … Read more
More than 22,000 American women are diagnosed with ovarian cancer each year. As Ovarian Cancer Awareness Month comes to a close, we believe in recognizing ovarian cancer organizations and advocates fighting to make a difference.
We’ve highlighted ovarian cancer organizations … Read more
By: Susan Gubar
As an ovarian cancer patient whose life is being extended by a clinical trial, I was delighted to learn this summer that research on gynecological cancers is undergoing an unusually productive period. But I’m dismayed that at … Read more
Cancer patients struggle to understand what is involved in a clinical trial, even when they have participated in them. In a survey of 1090 adult cancer patients, more than half did not understand the concepts of clinical equipoise or randomization.… Read more
By: Yadira Galindo
After spending 35 years as a community college counselor, Jo-Anne Lesser retired and was looking forward to traveling with her husband, Norman. Her plans were derailed when abdominal pains had her doubled over in agony.
For seven … Read more
It is difficult for advances to be made in rare cancers because there are fewer patients. This makes it more challenging to conduct clinical trials for these diseases. Rare ovarian cancers are no exception to this.
In an interview with … Read more
Over the past 20 years, Nazneen Rahman has identified a steady stream of genes that influence the risk of breast, ovarian, and childhood cancers—work that has earned her scientific, popular, and even royal acclaim. But her latest accomplishment, and one … Read more
Johnson & Johnson is an immense pharmaceutical and consumer products company of the type that the public loves to hate. Recently, it’s been getting absolutely killed by juries holding its baby powder responsible for causing several women’s ovarian cancers. The … Read more
Clinical trials may be a good treatment option for some patients with cancer, but these trials can be difficult to understand. Dr. Susan Gubar, a retired professor of English at Indiana University and author of Memoir of a Debulked Woman, … Read more
The statistics for ovarian cancer are frightening. Whereas early detection tests for breast cancer are relatively commonplace, 75-85% of women with ovarian cancer are diagnosed only at a late stage, when the cancer has spread and prognosis is poor.
More … Read more
